You just read:

Precision IBD Announces Next Phase Of Growth: Appoints Mark C. McKenna As President And Chief Executive Officer, Completes Name Change To Prometheus Biosciences, Inc.

News provided by

Prometheus Biosciences, Inc.

Sep 05, 2019, 14:52 ET